LASMIK® Low-Level Laser Therapy

Service Description

Supportive Physiotherapy in Oncology Care Euromed Alliance integrates Low-Level Laser Therapy (LLLT) using patented LASMIK® technology as a supportive physiotherapeutic modality within multidisciplinary oncology care. LASMIK® laser biomodulation is a non-invasive, non-thermal photobiomodulation method applied strictly as adjunctive therapy and does not replace standard oncologic treatment. Scientific Rationale The use of low-level laser biomodulation in oncology is supported by decades of experimental and clinical research, including randomized trials, systematic reviews, and consensus guidelines in photobiomodulation and physiotherapy. Published data describe regulatory biological effects without stimulation of malignant proliferation when applied within established therapeutic parameters. Documented physiological effects include: • Modulation of oxidative stress and inflammatory response • Improvement of microcirculation and tissue oxygen utilization • Support of immune regulation during cytotoxic therapy • Enhancement of cellular metabolism and mitochondrial activity • Improvement of hemorheological parameters (viscosity, aggregation) Clinical Applications LASMIK® LLLT is applied across all stages of cancer care: Pre-treatment: reduction of psychosomatic stress, optimization of adaptive reserves. During chemotherapy and radiotherapy: supportive management of treatment-related toxicity, reduction of pain, edema, inflammatory reactions, and early radiation-induced tissue damage. Post-treatment and rehabilitation: reduction of cancer-related fatigue, support of tissue repair, prevention of inflammatory and infectious complications, and adjunctive management of comorbid conditions. Therapeutic Integration Therapy is delivered in course-based, standardized protocols, individualized according to diagnosis and treatment phase. LASMIK® is frequently combined with ozone therapy, antioxidant IV support (e.g., glutathione), and metabolic support (e.g., NAD+). All procedures are performed under continuous medical supervision with laboratory monitoring. Safety & Evidence Positioning • Non-invasive and painless • No systemic toxicity or pharmacologic interaction • Compatible with chemotherapy, radiation therapy, and surgery LASMIK® laser biomodulation is positioned as an evidence-informed supportive physiotherapy modality, aligned with current photobiomodulation research and international safety recommendations for oncology supportive care.